Multiple studies in humans and mouse models indicate that sleep disruptions raise the risk of Alzheimer’s disease (AD) by increasing the accumulation of disease-relevant proteins…
Alzheimer’s disease and the urgent need for more effective treatments have been making headlines this year, with the FDA approving limited use of a new…
Studying tiny ‘live’ models of the human brain has helped researchers understand its aging and find a key to potential treatments for Alzheimer’s and other…
Aging-USÂ has published “Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer’s disease: an adrenergic approach” which reported that alzheimer’s disease, as the most…
Two drugs approved decades ago not only counteract brain damage caused by Alzheimer’s disease in animal models, the same therapeutic combination may also improve cognition.
Alzheimer’s disease and other types of dementia affect more than 55 million people worldwide. But the development of effective treatments and cures is progressing slowly.…
For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer’s disease and found that it…
A study by UT Southwestern researchers finds that changing the biochemistry of parts of brain cells abolished the formation of amyloid beta plaques in a…
One of the most commonly inherited forms of ALS and frontotemporal dementia is referred to as C9 ALS/FTD, so named for the repeated section of…
Individuals with Alzheimer’s disease or related dementias (ADRD) often experience behavioral and psychological symptoms such as depression, aggression and anxiety. Frequently, these symptoms are treated…